Partnerships 2010: New attendees, ideas, solutions and partnering opportunities!

Did you know over 70% of Partnerships in Clinical Trials Registered Attendees are New this Year?

Did you know over 60% of Registered Companies are New this Year?

With new attendees come new ideas, solutions and partnering opportunities.
Don’t miss out on your chance to make new strategic partnerships for 2010.

Take a look at a sample of who you will NETWORK with at the must-
attend event of the year:

* Abbott Laboratories * Abbott Vascular * Abraxis Biosciences * Acceleron Pharmaceuticals Inc * ACORN CRO * Alkermes Inc * Allos Therapeutics Inc * Almac Clinical Technology Inc * Amgen Inc * Array BioPharma Inc * Astellas Pharma Global Development * AstraZeneca Pharmaceuticals * Asubio Pharmaceuticals Inc * Baxter Healthcare Corporation * Bayer Healthcare Pharmaceuticals * Biogen Idec Inc * Biotest AG * BMS * Boehringer Ingelheim Pharmaceutical * Bristol Myers Squibb Company * C3i Inc * Calistoga Pharmaceuticals Inc * Cardiocore * Care Fusion * Celgene Corporation * Cephalon Inc * Cerexa Inc * Chexx Inc * Chiltern * Clearstone Central Laboratories * ClearTrial * Cognizant * Covance * Covidien * Cubist Pharmaceuticals Inc * Daiichi Sankyo Pharma Inc * Dainippon Sumitomo Pharma * DiagnoSearch Life Sciences * Drais * Pharmaceuticals Inc * Eisai Medical Research Inc * Elan Pharmaceuticals * Eli Lilly & Company * Endo Pharmaceuticals Inc * ERT * Eurofins Medinet * ExecuPharm Inc * F. Hoffmann-La Roche Ltd * Facet Biotech Corporation * FibroGen Inc * Forest Laboratories * Forest Research Institute * Genentech Inc * Genzyme Corporation * Gilead Sciences Inc * GlaxoSmithKline * Hoffmann La Roche Inc * Human Genome Sciences Inc * i3 Inc * ICON Clinical Research * INC Research * Incyte * inVentiv Clinical * Johnson & Johnson * Kendle * KForce Clinical Research * Lundbeck Inc * MacroGenics Inc * MakroCare * MedImmune Inc * Merck Research Laboratories * Metabolex Inc * Midas Pharmaceuticals Inc * Millennium Pharmaceuticals Inc * Mitsubishi Pharma Europe * Novartis Pharma AG * Novartis Pharmaceuticals * nSpire Health * OSI Pharmaceuticals Inc * Otsuka America Pharmaceuticals Inc * Otsuka Pharmaceutical Development Commercialization * Paragon Biomedical * Parexel International * Perceptive Informatics * Pfizer Inc * PharmaNet* Pharmasset * Phase Forward * PPD * PRA International * PSI * Purdue Pharma LP * Quintiles Transnational * Regeneron Pharmaceuticals Inc * Rigel Inc * Roche * RPS * Sanofi Pasteur * Sanofi-Aventis * Satori Pharmaceuticals Inc * Schering Plough * Sepracor Inc * Shire Human Genetic Therapies * Solvay Pharmaceuticals * Sticares InterACT * Stryker Spine * SuperGen * Takeda Pharmaceuticals * Teva Neuroscience Inc * United BioSource Corporation * UCB Inc * VDDI Pharmaceuticals * Vertex Pharmaceuticals * Viventia Biotechnologies Inc * Watson Pharmaceuticals * Xanodyne *

Are you ready to find your next strategic partner?

Register today to network and exchange solutions with nearly 2000 executives. Find the partner that will provide you with immediate solutions for your business needs.

Partnerships 2010: Getting to know Ethan Zohn: It's Stem-Cell Harvest Time

This year’s inspirational patient perspective at Partnerships in Clinical Trials is Survivor: Africa winner Ethan Zohn. Over the past few months, People.com has been documenting Ethan’s battle against Hodgkin’s Lymphoma. Last week, we looked at how Ethan felt about his stem cell transplants. This week, we're with Ethan while he is going through a stem-cell harvest. Click here to read the article.



This post is brought to you by:

Top Reasons to Attend the 2010 eClinical Technology Summit

The 14th Annual eClinical Technology Summit is next month. From April 12-14 in Orlando, Florida, you will have the opportunity to:

* Explore all new methods for integrating eclinical systems to improve data quality and drive efficiency

* Network with nearly 2000 clinical professionals from the co-located Partnerships in Clinical Trials event

* Master FDA guidelines and standardization initiatives to speed time to market

* Determine how to integrate and connect Electronic Health Records with your existing systems to boost patient and physician recruitment

To find out more about the event and download the brochure, visit the webpage.

Clayton Christensen on healthcare reform

Last year, Clayton Christensen, a keynote presenter at the 18th Annual Partnerships with CROs, focused on disruptive innovation in the Pharma industry as he discussed how it is on the precipice of major change where strategic sourcing/partnering approaches that provoke or complement disruptive change could be an important solution. In this portion of his speech, he looks at how the government could focus on creating a better and more affordable healthcare.

Watch it here:

This year, we’re excited to have , Jason Hwang, MD, MBA, Executive Director of Healthcare, Innosight Institute, who was the co-author of The Innovator’s Prescription: A Disruptive Solution for Health Care. He will be presenting the keynote speech, “Value Creation through strategic sourcing and new business Models," on Wednesday, April 14 at Partnerships in Clinical Trials. For more information on his presentation and others at Partnerships in Clinical Trials, download the brochure here.

Healthcare Reform and Pharmaceutical Development

We would like to welcome guest blogger Ronald Norton of Global Clinical Research Solutions, LLC to the Partnerships in Clinical Trails blog. You can visit the his webpage here. He can be reached at 850-556-7239.

With healthcare reform all over the news and an unending stream of 'pundits' offering their opinions, the question on my mind lately is, "How does this affect Pharma?" Specifically, " How does it affect product development costs and timelines?" And more to the point here, "How does it impact partnering in the business of planning and executing clinical trials?" Most of the chatter predicts a negative impact with forecasts ranging from minimally 'no help' on one hand to 'total meltdown' on the other. It shouldn't be too surprising that few are predicting improvement. Adding this kind of uncertainty to an environment already unsettled by the past year and a half of economic downturn, historically dwindling pipelines, recently increased FDA scrutiny, and seemingly unending layoffs at best lowers everyone's morale. Unfortunately, it also helps create a business environment where doing nothing seems better than acting on any new initiative. And, since pharma is a very conservative industry, the attitude is likely to be, "Let's just wait and see what falls out."

Our industry has a number of reasonably unique characteristics that exacerbate the effect of uncertainty like that associated with a regulatory change. Focusing on the financials, the cost of bringing a new drug to market of approximately $1 billion, and a timeline that can exceed a decade are among these characteristics. Targeting these characteristics produced the contract research industry and while those imperatives have not changed they are more pronounced now than they were a decade ago. Clearly successful partnering will still incorporate improvements to speed and costs on the one hand while retaining high quality on the other. However, creating meaningful partnerships in the clinical trials industry in today’s climate is a bit like going on a quest for the Holy Grail. There are lots of grails out there. Not many of them seem to be producing the desired effect. Why? And, will the much-discussed Healthcare

Reform initiative, if passed, create new opportunities? One thing is certain; it will bring speed, cost, and quality in clinical trial partnerships into higher relief.

With the Democrats claiming to be poised to pass the bill this week we will certainly hear more on this topic during the upcoming Partnerships in Clinical Trials Meeting next month in Orlando. You can expect that there will be more to post more on the subject.

Partnerships 2010: Getting to know Ethan Zohn: Ethan Talks about His Stem Cell Transplant

This year’s inspirational patient perspective at Partnerships in Clinical Trials is Survivor: Africa winner Ethan Zohn. Over the past few months, People.com has been documenting Ethan’s battle against Hodgkin’s Lymphoma. See how Ethan and his girlfriend, fellow Survivor contestant, Jenna Morasca, have come through the cancer treatments and how Ethan handled his stem cell transplant. Click here to read the article.


Watch the video here:

This post is brought to you by:

Central Labs West: In Pictures

This past February, we held Central Labs West in San Francisco, California. If you were unable to attend, we present you with Central Labs West: In Pictures.


Also, here are a few session write-ups:
Central Labs West: Welcome and Opening Remarks

Central Labs West: Rules for Becoming & Remaining a Scientist

Central Labs West: Featured Annual Report: Navigating the Stormy Seas of Pharmaceutical Innovation – Tufts CSdd’s Annual Report on Drug Development

Central Labs East will be taking place September 20-22, 2010 in Boston, Massachusetts. Visit the website to sign up for the latest updates on this exciting new agenda!

Clayton Christensen on small market versus blockbuster

Last year, Clayton Christensen, a keynote presenter at the 18th Annual Partnerships with CROs, focused on disruptive innovation in the Pharma industry as he discussed how it is on the precipice of major change where strategic sourcing/partnering approaches that provoke or complement disruptive change could be an important solution. In this portion of his speech, he looks at how blockbuster and small market drugs have changed over the past few decades.

Watch Part 3 of the presentation in the Multimedia box at the bottom of the page under “Video”:


This year, we’re excited to have , Jason Hwang, MD, MBA, Executive Director of Healthcare, Innosight Institute, who was the co-author of The Innovator’s Prescription: A Disruptive Solution for Health Care. He will be presenting the keynote speech, “Value Creation through strategic sourcing and new business Models, “ on Wednesday, April 14 at Partnerships in Clinical Trials. For more information on his presentation and others at Partnerships in Clinical Trials, download the brochure here.

Prepare for a major conference: Conference ROI

We would like to welcome guest blogger, Jared Byer, the Director of Marketing at Paragon Biomedical, Inc. He is also a frequent blogger on Paragon Biomedical’s blog ParaBioPlus.

Partnerships in Clinical Trials™ is among the most highly anticipated conferences in the global research industry because of its high quality content and its focused relevance to the entire clinical research community. And because planners have consistently developed compelling conference programs over the past 19 years, the annual event attracts nearly all major biopharmaceutical and medical device companies, clinical research organizations (CROs), central laboratories, data management shops, and other vendors that provide essential support and services to the industry.

As a full-service, global CRO, (and Gold Sponsor at the 2010 conference), Paragon Biomedical has devoted a lot of time to planning and preparation for this year’s conference. Even though Partnerships is one of the most competitively priced large events in the clinical research industry, it is still important to make sure your company offsets costs by maximizing the opportunities presented by attending.

To help in your planning, I’ll share the following guidelines Paragon Biomedical uses to prepare for a major conference.

1. Identify your overall objectives:
Increase sales opportunities by meeting with prospective clients.
Strengthen existing relationships.
Professional development.

2. Measure success; accurate measurements demand specific numbers, such as:
Meetings with existing or prospective clients.
Requests for a proposal (RFP).
Strategic partners identified.
Competitor assessments.

3. Validate conference alignment with your objectives:
Review the conference agenda outline to verify alignment.
Ensure expected input from lecturers and attendees is defined.

4. Communicate to your community:
After you have decided that a conference is a good fit for your company, develop and launch your outreach campaign.

An effective outreach campaign uses multiple channels. For example, you may combine direct conversations with emails and a press release.
Paragon uses this blog along with other social media, such as Twitter and LinkedIn, to maximize the value of conference attendance.

Partnerships 2010: Getting to know Ethan Zohn: Inside Ethan Zohn's Chemo Treatment

This year’s inspirational patient perspective at Partnerships in Clinical Trials is Survivor: Africa winner Ethan Zohn. Over the past few months, People.com has been documenting Ethan’s battle against Hodgkin’s Lymphoma. See how Ethan inspires and educates through his ordeal as he lets the camera roll in "the chemo zone.” Click here to read the article.

Click here to watch the video:


This post is brought to you by:

14th Annual eClinical Technology Summit

Partnerships in Clinical Trials is co-located with the 14th Annual eClinical Technology Summit in Orlando, taking place April 12-14, 2010.

As you know, the implementation of electronic technologies has tremendous potential for improving the productivity of drug research and development. However, the road to adoption across your organization can be difficult and the return on investment can be lost without enterprise-wide momentum and effective system integration.

The 14th Annual eClinical Technology Summit will introduce you to the next evolution of clinical data management. Join us for a Keynote presentation from Julia Zhang, Associate Director, Biomedical Sciences and Informatics, Genzyme, as she walks you through the changing clinical data management landscape and how the shift from paper to electronic data collection has impacted capture, quality, integration, and management of clinical trials.
Plus, find out how the shift in pharma and biotech pipelines from the “blockbuster” to the “nichebuster” will impact R&D, including clinical trials, with a Keynote presentation from Chris Anderson, Editor in Chief, Wired Magazine and Bestselling author of “The Long Tail”. Thomas Senderovitz, MD, Vice President, Exploratory Medicine, UCB Pharma, will expand upon this theory and how it will drive future innovation, pipeline growth, and revenue.

Don’t miss this year’s best opportunity to obtain cutting edge data management techniques and learn how your industry peers are putting clinical trial innovation into practice through the strategic implementation of eclinical technologies. Be sure to register by Friday, March 5 to save $200!

Download the brochure here.
Visit the webpage here.

Partnerships 2009: Understanding the Concepts of Disruptive Innovation, Its Impact and What Pharma Can Do to Get Ahead of It

Last year, Clayton Christensen, a keynote presenter at the 18th Annual Partnerships with CROs, focused on disruptive innovation in the Pharma industry as he discussed how it is on the precipice of major change where strategic sourcing/partnering approaches that provoke or complement disruptive change could be an important solution. Join esteemed academician, business thought leader and bestselling author, Clayton Christensen draws parallels between the current Pharma industry and the steel mill industry in Pennsylvania.

Watch Part 1 and Part 2 of the presentation in the Multimedia box at the bottom of the page under “Video”:





This year, we’re excited to have , Jason Hwang, MD, MBA, Executive Director of Healthcare, Innosight Institute, who was the co-author of The Innovator’s Prescription: A Disruptive Solution for Health Care. He will be presenting the keynote speech, “Value Creation through strategic sourcing and new business Models, “ on Wednesday, April 14 at Partnerships in Clinical Trials. For more information on his presentation and others at Partnerships in Clinical Trials, download the brochure here.

Partnerships in Clinical Trials Speakers on ‘Virtual’ Drug Development Teams: Solomon Babani & Karen Sobel Lojeski

Recently, Solomon Babani, Director of Outsourcing and Vendor Management, Celtic Pharma and Therapeutic Development Services and Karen Sobel Lojeski, PhD, Professor at Stony Brook University and Founder of Virtual Distance International sat down with the Partnerships team to discuss their views that have influenced their upcoming workshop "Workforce Transformation: Leading Effective Cross-Functional Teams in a Matrix Environment". Listen to their podcast below:

Discover Simple, Private Sharing at Drop.io

Download the podcast here.
Download the podcast transcript here.
Find out more about the workshop and the Partnerships in Clinical Trials program by downloading the brochure here.

Partnerships 2010: Getting to know Ethan Zohn

With this year’s inspirational patient perspective, the Survivor: Africa winner Ethan Zohn discusses his battle with cancer and the personal impact the pharmaceutical industry has had on his life. Over the past few months, People.com has been documenting his experience while he is on his quest to cure cancer. This week we have Ethan Zohn's 5:30 A.M. Tour of N.Y.C. Read the full article here.

Click to watch the video:

This post is brought to you by: